Planet Labs (PL) director Vijaya Gadde awarded 6,479 RSUs in new equity grant

Rhea-AI Filing Summary

Gadde Vijaya reported acquisition or exercise transactions in this Form 4 filing.

Planet Labs PBC reported that director Vijaya Gadde received a grant of 6,479 shares of Class A Common Stock in the form of restricted stock units. Following this award, Gadde holds 256,648 shares directly. The RSUs vest fully on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, subject to continuous service.

Insights

Equity compensation analyst

Routine director equity award that modestly increases alignment with shareholders.

Director Vijaya Gadde received a grant of 6,479 restricted stock units, each representing one share of Class A Common Stock. The award was recorded at a price of $0.00 per share, consistent with standard equity compensation grants rather than a market purchase.

The RSUs vest entirely on the earlier of the first anniversary of the grant or the next annual meeting of stockholders, conditioned on continuous service. After this grant, Gadde directly holds 256,648 shares, so the award is incremental to an existing position and appears as routine board compensation rather than a thesis-changing event.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gadde Vijaya

Role null

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock	6,479	$0.00	--

Holdings After Transaction: Class A Common Stock — 256,648 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 6,479 shares Shares held after transaction: 256,648 shares Grant price per share: $0.00 +1 more

4 metrics

RSUs granted 6,479 shares Restricted stock units representing Class A Common Stock granted to director Vijaya Gadde

Shares held after transaction 256,648 shares Total direct holdings of Vijaya Gadde following the RSU award

Grant price per share $0.00 Reported transaction price per share for the RSU grant

Vesting condition earlier of first anniversary or next annual meeting RSUs vest fully on the earlier of these dates, subject to continuous service

Key Terms

restricted stock units, continuous service, annual meeting of stockholders

3 terms

restricted stock units financial

"Includes 6,479 restricted stock units, each of which represent a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

continuous service financial

"subject to continuous service through the vesting date"

annual meeting of stockholders financial

"the date of the Issuer's next annual meeting of stockholders to occur"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/10/2026 - 04:17 PM Accepted by SEC EDGAR 07/10/2026 - 04:17 PM Learn about SEC filing dates

FAQ

What did Vijaya Gadde acquire in Planet Labs PBC (PL) according to this Form 4?

Vijaya Gadde received a grant of 6,479 restricted stock units, each representing one share of Planet Labs PBC Class A Common Stock. This is an equity compensation award, not an open-market stock purchase.

How many Planet Labs (PL) shares does Vijaya Gadde hold after this reported transaction?

After the reported grant, Vijaya Gadde directly holds 256,648 shares of Planet Labs PBC Class A Common Stock. This total includes the newly awarded 6,479 restricted stock units once they settle into shares.

What are the vesting terms of Vijaya Gadde’s 6,479 RSUs in Planet Labs (PL)?

The 6,479 RSUs fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the next Planet Labs annual meeting of stockholders, in each case subject to Gadde’s continuous service through the vesting date.

Was Vijaya Gadde’s Planet Labs (PL) Form 4 transaction a market purchase or a grant?

The Form 4 reports a grant or award acquisition of 6,479 RSUs at a reported price of $0.00 per share. It reflects equity compensation, not an open-market buy or sell transaction.

Does the Planet Labs (PL) Form 4 show any insider sales by Vijaya Gadde?

No insider sales are reported. The Form 4 discloses only a single acquisition of 6,479 RSUs by Vijaya Gadde and shows no dispositions or sales of Planet Labs shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gadde Vijaya

(Last) (First) (Middle)

C/O PLANET LABS PBC

645 HARRISON STREET

(Street)

SAN FRANCISCO CALIFORNIA 94107

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Planet Labs PBC [ PL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/09/2026		A		6,479(1)	A	$0	256,648	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 6,479 restricted stock units, each of which represent a contingent right to receive one share of issuer's Class A Common Stock ("RSUs"). The RSUs will fully vest on the earlier of (i) the first anniversary of the grant or (ii) the date of the Issuer's next annual meeting of stockholders to occur following the grant, in either case, subject to continuous service through the vesting date.

	By: /s/ LeeAnn Linck, Attorney-in-fact for: Vijaya Gadde	07/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)